CS27109, A Selective Thyroid Hormone Receptor-β Agonist Alleviates Metabolic-Associated Fatty Liver Disease in Murine Models
Background/Aim. Thyroid hormone receptor-β (THR-β) agonists play crucial roles in dyslipidemia and metabolic associated fatty liver disease (MAFLD). We developed a novel oral and liver-targeted THR-β agonist, CS27109, and evaluated its efficacy in the treatment of metabolic disorders. Materials and...
Saved in:
| Main Authors: | Shengjian Huang, Zhou Deng, Wei Wang, Guoqiang Liao, Yiru Zhao, Hua Zhong, Qian Zhang, Jing Liu, Xuhua Mao, Beizhong Chen, Desi Pan, You Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2023/4950597 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thyroid Dysfunction after Gonadotropin-Releasing Hormone Agonist Administration in Women with Thyroid Autoimmunity
by: Loris Marin, et al.
Published: (2022-01-01) -
The role of thyroid hormones in regulating of fatty acid spectrum of brain lipids: ontogenetic aspect.
by: A. G. Rodynskiy, et al.
Published: (2016-05-01) -
The thyroid and the thyroid hormones (in Romanian)
by: Andreea Pap,, et al.
Published: (2014-12-01) -
Clinical Evaluation of Various Thyroid Hormones on Thyroid Function
by: Hong Li, et al.
Published: (2014-01-01) -
HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER
by: K. M. Nyushko, et al.
Published: (2015-01-01)